Ignite Creation Date:
2024-10-26 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06539923
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-08-01
Brief Title:
Sarcopenic Index and Related Factors in Patients With Type 2 Diabetes
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Sarcopenic Index and Related Factors in Patients With Type 2 Diabetes Applying to Tertiary Health Care Services
Status:
COMPLETED
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Sarcopenia characterized by a progressive loss of skeletal muscle mass and function is particularly common in individuals with T2DM and is often associated with insulin resistance chronic inflammation and oxidative stress The Sarcopenia Index SI calculated as serum creatinine divided by serum cystatin C is a practical tool for assessing sarcopenia and is used in many clinical settings In this study we aimed to investigate the relationship between sarcopenic index and variables such as age diabetes duration diabetes control and complication-related parameters such as NT-proBNP and Fib4 score in patients with type 2 diabetes
Detailed Description:
This study was planned retrospectively Between September 01 2023 and March 31 2024 the records of patients who presented to the Diabetes Outpatient Clinic of Goztepe Prof Dr Suleyman Yalcin City Hospital for Internal Medicine and whose routine biochemical tests including NT-proBNP and cystatin C were found in the system will be retrospectively reviewed Both male and female patients with a definite diagnosis of type 2 diabetes were included in the study Inclusion criteria included age 40 years or older age 85 years or younger no acute infection no steroid use no acute changes in creatinine or cystatin C levels no recent surgery no limb loss Demographic data included age gender duration of diabetes medications and concomitant diseases The Fib 4 score was calculated using the patients routine biochemical and hematologic results The sarcopenia index was calculated from the serum creatininecystatin C values A cut-off value of 090 is normally used for the diagnosis of sarcopenia in people without diabetes but there is no cut-off value for patients with diabetes Therefore in addition to the correlation the SI value was divided into 3 groups and the patients in the lowest and highest groups were compared with each other
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None